1
Clinical Trials associated with GSK-586529A Single Blind, Randomized, Placebo Controlled, Crossover Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Oral Escalating Doses of GSK586529 in Healthy Volunteers
A single blind, randomized, placebo-controlled, crossover study in twenty four healthy male subjects. Subjects will be divided into two cohorts with alternate panel design. The study is investigating the safety, tolerability and pharmacokinetics of single oral escalating doses of GSK586529.
100 Clinical Results associated with GSK-586529
100 Translational Medicine associated with GSK-586529
100 Patents (Medical) associated with GSK-586529
100 Deals associated with GSK-586529